Back to Archived Journals » Core Evidence » Volume 6 » default
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 6, 2011
Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes
Barnett AH
Core Evidence 2011, 6:67-79
Published Date: 8 September 2011
Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review
Kirkby S, Novak K, McCoy K
Core Evidence 2011, 6:59-66
Published Date: 11 August 2011
Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma
Jain S, Diefenbach C, Zain J, O'Connor OA
Core Evidence 2011, 6:43-57
Published Date: 4 April 2011
Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes
Bernardo Lombo, José G Díez
Core Evidence 2011, 6:31-42
Published Date: 17 March 2011
Plerixafor for autologous CD34+ cell mobilization
Huda Salman, Hillard M Lazarus
Core Evidence 2011, 6:23-29
Published Date: 8 February 2011
Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis
Emilio Portaccio
Core Evidence 2011, 6:13-21
Published Date: 6 January 2011
Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma
Brian Poligone, Janet Lin, Catherine Chung
Core Evidence 2011, 6:1-12
Published Date: 22 December 2010